Analysis of Change Inc. (3962)
Based on the provided data for Change Inc. stock (symbol: 3962) for the last 10 days:
1. **Price Movement**: The closing prices have been fluctuating, ranging from 1181 to 1274. There is no clear trend in the closing prices over the past 10 days.
2. **Relative Strength Index (RSI)**: The RSI values have been fluctuating around the mid-range (30-70), indicating a lack of strong overbought or oversold conditions. The RSI values range from 37.75 to 62.32.
3. **Moving Average Convergence Divergence (MACD)**: The MACD indicator has shown some variability, with both positive and negative values. The MACD histogram has been fluctuating, indicating some volatility in the stock price momentum.
4. **Moving Averages (MA)**: The Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) have been calculated for each day. These moving averages can help identify potential support and resistance levels.
5. **Overall Analysis**: The stock seems to be experiencing some volatility with no clear trend in the closing prices. The RSI values suggest a lack of strong buying or selling pressure. The MACD indicator shows some fluctuations in momentum, and the moving averages can provide insights into potential price levels.
6. **Recommendation**: Given the mixed signals from the indicators and the lack of a clear trend, it may be prudent for investors to wait for more stable price movements or additional confirmatory signals before making trading decisions.
Please note that this analysis is based on the provided data and does not take into account external factors that may influence the stock price.
Income statement 💸
Here are the revenue figures for the past four fiscal years:
1. Fiscal Year 2023: Sales of $383,285,000,000
2. Fiscal Year 2022: Sales of $394,328,000,000
3. Fiscal Year 2021: Sales of $365,817,000,000
4. Fiscal Year 2020: Sales of $274,515,000,000
From these figures, we can observe the following trends:
- There was a decrease in sales from FY 2022 to FY 2023.
- Prior to FY 2023, there was a general increasing trend in sales over the years.
- The highest sales figure was recorded in FY 2022.
These trends can provide insights into the company's performance and market conditions over the specified fiscal years.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.
Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuations metrics, stock price summary, and dividends and splits information for a specific company.
In terms of financials, the company has strong cash flow with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet shows a total cash of $67.15 billion, total debt of $104.59 billion, and a current ratio of 1.037. The profit margin is 26.31% and the company's fiscal year ends on September 30, 2023. The income statement reveals an EBITDA of $131.39 billion, revenue of $381.62 billion, and a diluted EPS of 6.43.
Moving on to stock statistics, the company has a short ratio of 1.53, with 99.29 million shares shorted out of 15.31 billion float shares. The average trading volume is 46.86 million shares over 10 days and 57.50 million shares over 90 days. The stock outstanding is 15.33 billion shares, with 5.22% held by insiders and 57.59% held by institutions.
Valuation metrics show a PEG ratio of 26.32, forward PE of 26.32, and trailing PE of 29.59. The enterprise value is $2.95 trillion, with a price to book ratio of 39.34 and price to sales ratio of 7.65. The enterprise to EBITDA ratio is 22.76 and enterprise to revenue ratio is 7.73. The market capitalization is $2.92 trillion.
The stock price summary includes a beta of 1.26, 50-day moving average of $176.26, 200-day moving average of $181.04, a 52-week low of $164.08, high of $199.62, and a 52-week change of 6.85%.
Lastly, dividends and splits information shows a payout ratio of 14.93%, with a dividend date on May 16, 2024. The last split date was on August 31, 2020, with a 4-for-1 split factor. The forward annual dividend rate is $1, with a 5-year average dividend yield of 0.73% and a forward annual dividend yield of 0.53%. The trailing annual dividend rate is $0.97, with a trailing annual dividend yield of 0.51%.
Balance Sheet
These are balance sheets. Here are the conclusions:
1. The total assets have been increasing over the years, reaching the highest value in 2023 at $352,755,000,000.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2023 at $217,350,000,000.
4. Total liabilities have also been increasing, reaching the highest value in 2023 at $302,083,000,000.
5. Shareholders' equity has been fluctuating, with the highest value in 2018 at $107,147,000,000.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:
1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. Financing activities have a significant impact on the company's cash position, with large amounts being used for common stock repurchase and debt issuance.
4. Investing activities show a mix of acquisitions, capital expenditures, and investments, which have varied in magnitude over the years.
5. The company has been consistently paying interest and income taxes, which are important factors to consider in assessing its financial health.
6. The end cash position has also been fluctuating, reflecting the overall cash management and financial performance of the company.
Earnings estimate
The analysts' estimates for future quarterly and annual earnings per share are as follows:
1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.23
- Low Estimate: $1.18
- High Estimate: $1.26
- Year Ago EPS: $1.17
- Number of Analysts: 27
2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.42
- Low Estimate: $1.33
- High Estimate: $1.51
- Year Ago EPS: $1.35
- Number of Analysts: 26
3. Current Year (as of September 30, 2024):
- Average Estimate: $6.10
- Low Estimate: $5.95
- High Estimate: $6.41
- Year Ago EPS: $5.67
- Number of Analysts: 40
4. Next Year (as of September 30, 2025):
- Average Estimate: $6.69
- Low Estimate: $5.92
- High Estimate: $7.31
- Year Ago EPS: $6.10
- Number of Analysts: 40
Based on these estimates, we can see a generally positive trend in expected earnings per share both for the upcoming quarters and the next year. The average estimates are increasing, which indicates potential growth in earnings for the company. It's also worth noting that the number of analysts providing estimates is relatively high, adding credibility to these projections.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:
1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
Overall, the analysts are generally optimistic about the company's future sales performance, with moderate growth expected in both the quarterly and annual sales figures.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:
1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is slightly higher at 5.2%.
3. Current Year: The growth rate for the current year is estimated to be 7.6%.
4. Next Year: The growth rate is expected to increase further to 9.7% in the next year.
5. Past 5 Years: The company has shown a strong growth rate of 20.1% on average over the past 5 years.
6. Next 5 Years: Looking ahead, analysts project a growth rate of 9.7% per year on average for the next 5 years.
Overall, the company is expected to maintain a solid growth trajectory, with a slight increase in growth rates in the upcoming periods compared to the current ones.
Price target
Based on the analysts' forecast, the future price of the security is expected to range between $164 (low) and $250 (high), with a median estimate of $200 and an average estimate of $202.26. The current price of the security is $191.57.MACD of 3962